Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-278319
Filing Date
2025-11-12
Accepted
2025-11-12 20:16:46
Documents
1
Period of Report
2025-11-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6580
  Complete submission text file 0001193125-25-278319.txt   9285
Mailing Address C/O SILVER POINT CAPITAL L.P. TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830
Business Address
MULE EDWARD A (Reporting) CIK: 0001029625 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 251475001

Mailing Address TWO GREENWICH PLAZA, SUITE 1 GREENWICH CT 06830
Business Address TWO GREENWICH PLAZA, SUITE 1 GREENWICH CT 06830 (203) 542-4000
Silver Point Capital L.P. (Reporting) CIK: 0001332784 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 251475002

Mailing Address C/O SILVER POINT CAPITAL L.P. TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830
Business Address
O'Shea Robert J (Reporting) CIK: 0001382617 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 251475000

Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Keenova Therapeutics plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)